The healthcare industry has been in the limelight since the onset of the COVID-19 pandemic and has remained under pressure as variants of the virus have emerged several times over the past two years. Medical experts and the CDC are now warning about a potential fourth wave as cases rise again in China and several European countries.
Biotech companies and governments have invested heavily to control the pandemic, including significant investments to create effective vaccines for all ages and to fund mass vaccination drives.
